CN1569027A - Powdered eye disease treating medicine - Google Patents

Powdered eye disease treating medicine Download PDF

Info

Publication number
CN1569027A
CN1569027A CN 200310100898 CN200310100898A CN1569027A CN 1569027 A CN1569027 A CN 1569027A CN 200310100898 CN200310100898 CN 200310100898 CN 200310100898 A CN200310100898 A CN 200310100898A CN 1569027 A CN1569027 A CN 1569027A
Authority
CN
China
Prior art keywords
medicine
eye disease
bulbar conjunctiva
ophthalmias
disease treating
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN 200310100898
Other languages
Chinese (zh)
Other versions
CN1245990C (en
Inventor
王敏
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN 200310100898 priority Critical patent/CN1245990C/en
Publication of CN1569027A publication Critical patent/CN1569027A/en
Application granted granted Critical
Publication of CN1245990C publication Critical patent/CN1245990C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

The invention provides a medicament for treating leukoma of cornea and other eye diseases, which is prepared from calamine, boneol, borax, and compound of glauber-salt and liquorice.

Description

Powder ophthalmia medicine
The present invention relates to a kind of Chinese patent drug, dry powder medicament for the eyes is particularly treated the medicine of all ophthalmias and nebula film bulbar conjunctiva polyp.
At present, what sell on the market is moist medicament for the eyes, is used for treating ophthalmia, various in style, and effect is all separated even differing, and nebula film bulbar conjunctiva polyp need be performed the operation and could be cured, and its safety is very unstable yet, recovers to take regular hour etc., suchlike problem yet.
The purpose of this invention is to provide a kind of all ophthalmias of treatment, and the medicine of nebula film bulbar conjunctiva polyp, it is a kind of dryness powder, promptly can treat eyeball and cut ophthalmia, can come stablely and true effect for moist medicament for the eyes, can be beneficial to treatment nebula film bulbar conjunctiva polyp again, the risk that prevents to perform the operation and also come.
For reaching above-mentioned purpose, the technical solution used in the present invention is: get Chinese medicine (mass ratio), comprising: Calamina 52.6%, Borneolum Syntheticum 5.3%, Borax 15.8%, Matrii Sulfas Exsiccatus 26.3%
With behind the above-mentioned Chinese medicine superfine powder uniform mixing the medicine of treatment all ophthalmias and nebula film bulbar conjunctiva polyp.
All ophthalmias of treatment of the present invention and nebula film bulbar conjunctiva polyp need use by fixed mode
It is an amount of to get above-mentioned medicine, splashes into ophthalmic, one day several (more than 3 times or 3 times)
Above-mentioned Chinese medicine proportioning shapes (sublimed preparation) and is preferred version of the present invention
The present invention has above advantage:
1, because this product is a kind of sublimed preparation, is suitable for and deposits, also indeformable.
2, owing to use this medicine, pleasing to the eye i.e. effect, and use other moist medicament for the eyes to need take effect in 2-3 days, treat nebula film bulbar conjunctiva polyp simultaneously need not perform the operation the risk that also prevents to perform the operation and bring.
3, Borneolum Syntheticum, Borax, Matrii Sulfas Exsiccatus purpose have been appraised and decided its antiinflammation from name side's Chinese patent medicine BINGPENG SAN, are better than other moist medicament for the eyes, and adding Calamina is for the removing nebula function of improving eyesight, strengthens above-mentioned three medicine functions simultaneously, use with a medicine so can reach one more.

Claims (2)

1, a kind of medicine for the treatment of all ophthalmias and nebula film bulbar conjunctiva polyp, composition comprises (mass ratio).
Calamina 52.6%, Borneolum Syntheticum 5.3%, Borax 15.8%, Matrii Sulfas Exsiccatus 26.3%
2, the medicine of all ophthalmias of treatment according to claim 1 and nebula film bulbar conjunctiva polyp is characterized in that: with Chinese medicine Calamina, Borneolum Syntheticum, Borax, four kinds of powder mixes of Matrii Sulfas Exsiccatus evenly after, medicine.
CN 200310100898 2003-10-15 2003-10-15 Powdered eye disease treating medicine Expired - Fee Related CN1245990C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN 200310100898 CN1245990C (en) 2003-10-15 2003-10-15 Powdered eye disease treating medicine

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN 200310100898 CN1245990C (en) 2003-10-15 2003-10-15 Powdered eye disease treating medicine

Publications (2)

Publication Number Publication Date
CN1569027A true CN1569027A (en) 2005-01-26
CN1245990C CN1245990C (en) 2006-03-22

Family

ID=34473848

Family Applications (1)

Application Number Title Priority Date Filing Date
CN 200310100898 Expired - Fee Related CN1245990C (en) 2003-10-15 2003-10-15 Powdered eye disease treating medicine

Country Status (1)

Country Link
CN (1) CN1245990C (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100370979C (en) * 2006-02-22 2008-02-27 黎秋萍 Prepn process of glucose eye lotion
CN102370658A (en) * 2011-10-28 2012-03-14 于强 Eyedrops for treating presbyopia and preparation method thereof
CN109223823A (en) * 2018-10-26 2019-01-18 邸树红 A kind of acute lumbar muscle sprain eye droppings dissipates and preparation method thereof

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100370979C (en) * 2006-02-22 2008-02-27 黎秋萍 Prepn process of glucose eye lotion
CN102370658A (en) * 2011-10-28 2012-03-14 于强 Eyedrops for treating presbyopia and preparation method thereof
CN102370658B (en) * 2011-10-28 2013-10-02 于强 Eyedrops for treating presbyopia and preparation method thereof
CN109223823A (en) * 2018-10-26 2019-01-18 邸树红 A kind of acute lumbar muscle sprain eye droppings dissipates and preparation method thereof

Also Published As

Publication number Publication date
CN1245990C (en) 2006-03-22

Similar Documents

Publication Publication Date Title
Liang et al. Melatonin protects human retinal pigment epithelial (RPE) cells against oxidative stress
US7674486B2 (en) Synergistic composition for the treatment of diabetes mellitus
CN108904633A (en) A kind of eye ointment and preparation method thereof improving eyesight
CN1569027A (en) Powdered eye disease treating medicine
CN105105316B (en) A kind of agilawood essential oil atomized liquid and preparation method thereof
CN102648948B (en) Fumigation Chinese medicinal composition for eye protection
CN107441159A (en) A kind of alleviation visual fatigue, the Chinese medicine composition of mist, its eye sticker and preparation method
KR20090049390A (en) The manufacturing method of natural unfalling out of hair
US20210228516A1 (en) Eye drops that cure cataracts presbyopia and
CN1498633A (en) Oral liquid for treating ophthalmic diseases
CN1161202A (en) Non-scar type prepns. for treating burns or scald, and its ingredients
CN1172711C (en) Chinese medicine preparation for curing chronic conjunctivitis
JP4921165B2 (en) Flupirtine formulation for the treatment of neurodegenerative diseases of the visual organs and diabetes mellitus
CN105902686A (en) In-situ gel eyewash containing nano-carbon crystals and preparation method thereof
CN104306764B (en) A kind of Chinese medicine compound prescription spray for being used to control rhinitis
CN116803408A (en) Formula for inhibiting sexual dysfunction
CN1060380C (en) Medicine for treating and healing wound
US20160129052A1 (en) Use of propolis for combating the side effects of chemotherapy
CN115154580B (en) Traditional Chinese medicine composition for treating corneal pannus, medicine and preparation method of medicine
CN104814963B (en) A kind of medical composition and its use containing istradefylline
CN100415293C (en) Biological collagen oral liquor and preparing method
KR100311761B1 (en) Method for producing healthy drug using aloe and garlic
US7736676B2 (en) Synergistic composition for the treatment of diabetes mellitus
JPH02264726A (en) Herb tea for pollen allergic disease
CN107362185A (en) Application and medicine of the little Hua Asystasia gangetica (L) Anders.(A. Coromandelihas Nees)s in the medicine for preparing prevention and/or treatment nerve degenerative diseases

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
C19 Lapse of patent right due to non-payment of the annual fee
CF01 Termination of patent right due to non-payment of annual fee